HeiQ Viroblock

Industry

  • Medical Devices
    • Infection Control-Sterilization
  • Biotechnology
    • Liposomes
  • Pharmaceuticals
See more in Biomedtracker

Latest on HeiQ Viroblock

Scrip

Start-Up Execs On The Move, April 2012

 
• By Regina Paleski

Start-Up Execs arGEN-X NV Alain Thibault, MD To:CMO (March) From:Therapeutic Area Head, Oncology, Regeneron Pharmaceuticals Inc. Tel:+31 10 70 38 441 Constellation Pharmaceuticals Inc. Keith E

Scrip

Start-Ups Look For Places In Future HCV Combo Regimens

With approval of direct-acting hepatitis C therapies just around the corner, start-ups are looking to provide parts of the puzzle in next-generation drug cocktails for treating the growing disease. Fo

Scrip

Viroblock SA

 
• By Deborah Erickson

Pitting cyclodextrin again viruses, first in face masks Chemin des Aulx 18 1228 Plan-les-Ouates, Geneva, Switzerland Phone: +41 22 884 8346 Web Site: www.viroblock.com Contact: Jamie Paterson, CEO Ind

In Vivo

Start-Up Previews (11/2010)

Start-Ups Look For A Place In HCV Combo Regimens In the four years since AiCuris GMBH & Co. KG spun out of Bayer HealthCare's anti-infectives unit, it has continued to advance its inherited pipeli